THE WHAT? Private equity firm Ardian has snapped up a majority stake in Italy’s Biofarma from White Bridge Investments.
THE DETAILS The Scarpa family will retain its current 30 percent stake in the group and Maurizio Castorina will remain in situ as CEO.
The partnership with Ardian will facilitate further consolidation and international development, through continued investment in technological excellence, offer diversification and formulation of new products and, at the same time, preserve the current corporate culture.
THE WHY? Yann Chareton, Ardian Managing Director, commented, “The nutraceutical sector is already benefitting from strong growth driven by secular trends, such as the importance attributed by customers to prevention, and Italy represents an excellence in this market recognised worldwide. Biofarma is undoubtedly the technological leader and natural consolidator of the industry, so we are very pleased to partner-up with the Group’s management and the Scarpa family on this project, which will lead to an acceleration of Biofarma’s growth, also at an international level.”